TW202430507A - 新穎atp-敏感性鉀通道增效劑、其製備及用途 - Google Patents

新穎atp-敏感性鉀通道增效劑、其製備及用途 Download PDF

Info

Publication number
TW202430507A
TW202430507A TW112139862A TW112139862A TW202430507A TW 202430507 A TW202430507 A TW 202430507A TW 112139862 A TW112139862 A TW 112139862A TW 112139862 A TW112139862 A TW 112139862A TW 202430507 A TW202430507 A TW 202430507A
Authority
TW
Taiwan
Prior art keywords
preparation
potentiators
potassium channel
sensitive potassium
hyperinsulinism
Prior art date
Application number
TW112139862A
Other languages
English (en)
Inventor
皮耶特 維傑尼克
德 桑迪 克勞汀 凡
博特蘭 維偉特
羅倫斯 安 梅維勒
Original Assignee
美商律森製藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商律森製藥股份有限公司 filed Critical 美商律森製藥股份有限公司
Publication of TW202430507A publication Critical patent/TW202430507A/zh

Links

Abstract

本發明係關於通式(I)化合物或其醫藥上可接受之鹽、溶劑合物及/或水合物、其製備方法、該等化合物用作藥劑之用途及其等於治療及/或預防疾病或疾患之用途。在一實施例中，該疾病或疾患係高胰島素血症，特定言之先天性高胰島素血症。本發明亦係關於包含通式(I)化合物及醫藥上可接受之載劑之醫藥組合物及其用作藥劑之用途，特定言之其於治療疾病或疾患(諸如高胰島素血症或先天性高胰島素血症)之用途。
TW112139862A 2022-10-18 2023-10-18 新穎atp-敏感性鉀通道增效劑、其製備及用途 TW202430507A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL2033343 2022-10-18

Publications (1)

Publication Number Publication Date
TW202430507A true TW202430507A (zh) 2024-08-01

Family

ID=

Similar Documents

Publication Publication Date Title
WO2021147236A9 (zh) 取代氨基丙酸酯类化合物在治疗SARS-CoV-2感染中的应用
MX2022008066A (es) Compuestos triciclicos sustituidos.
MX2022006475A (es) Compuestos triciclicos sustituidos.
MX2022015622A (es) Compuestos de dihidroquinolin sulfonamida de ciclopropilo.
WO2001064639A3 (en) Pde iv inhibiting amides, compositions and pharmaceutical use
TWI327573B (en) 6-11 bicyclic ketolide derivatives
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
IL276194B2 (en) Pharmaceutical compounds or preparations containing them for use in the treatment of pain
WO2004096823A3 (en) Novel ketolide derivatives
WO2019207257A8 (fr) Composes a activite inhibitrice de la polymerisation de la tubuline et aux proprietes immunomodulatrices
WO2006039263A3 (en) NOVEL BICYCLIC 9a-AZALIDE DERIVATIVES
MX2023006504A (es) Compuesto de hidroxamato, metodo de preparacion del mismo y aplicacion del mismo.
PH12021550878A1 (en) Cyclodextrin-based formulation of a bcl-2 inhibitor
WO2003049676A3 (en) Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the teatment of cancer
EP1864662A1 (en) Therapeutic agent for thrombosis
MX2023003576A (es) Compuesto como inhibidor de la akt cinasa.
IL276311B2 (en) Methyllactam ring compound and its pharmaceutical use
WO2008065444B1 (en) Substituted quinazolines
TW202430507A (zh) 新穎atp-敏感性鉀通道增效劑、其製備及用途
CA3155875A1 (en) BIARYL COMPOUND SUBSTITUTED BY SULFO OR CORRESPONDING SALT, METHOD FOR PREPARATION AND USE
WO2003089446A3 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
WO2020251871A3 (en) Novel substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (ido) inhibitors
MX2023011297A (es) Antagonista del dominio de alfa/beta hidrolasa 6 (abhd6).
WO2022104153A3 (en) Compounds and methods for treating viral infections
MX2022009898A (es) Compuesto de dihidronaftiridinona y metodo de preparacion del mismo y uso medico del mismo.